Thyrocare Expects 84.9% Year-on-Year Increase in Q4 Net Profit
ICICI Securities Releases Q4 Earnings Estimates for Healthcare Sector
ICICI Securities has published its earnings estimates for the Healthcare sector, focusing on the fourth quarter of the fiscal year 2022-2023, spanning January to March 2026. According to the brokerage house, Thyrocare is expected to report a net profit of Rs. 40.1 crore, marking a significant year-over-year increase of 84.9%.
The estimated net sales for Thyrocare are projected to rise by 14.3 percent year-over-year, reaching Rs. 214 crore. On a quarterly basis, the net sales are expected to increase by 9.4 percent.
Earnings before interest, tax, depreciation, and amortisation (EBITDA) are likely to experience a notable growth, with an estimated rise of 16.8 percent year-over-year, reaching Rs. 67.4 crore. On a quarterly basis, EBITDA is expected to increase by 16.6 percent.
| Metric | Q4 FY 2022-23 (Estimate) | Q-o-Q Growth | Y-o-Y Growth |
|---|---|---|---|
| Net Profit (Rs. crore) | 40.1 | 18.4% | 84.9% |
| Net Sales (Rs. crore) | 214 | 9.4% | 14.3% |
| EBITDA (Rs. crore) | 67.4 | 16.6% | 16.8% |
Investor Takeaway
Investors can expect a significant increase in Thyrocare's net profit in Q4.
More in Market
SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire
Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
